These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8778315)
1. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315 [TBL] [Abstract][Full Text] [Related]
2. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744 [TBL] [Abstract][Full Text] [Related]
3. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study. Cardillo MR; Yap EP Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283 [TBL] [Abstract][Full Text] [Related]
5. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082 [TBL] [Abstract][Full Text] [Related]
6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study. Cardillo MR; Yap E J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902 [TBL] [Abstract][Full Text] [Related]
8. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902 [TBL] [Abstract][Full Text] [Related]
9. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis. Jiang PS; Yung BY Biochem Biophys Res Commun; 1999 Apr; 257(3):865-70. PubMed ID: 10208875 [TBL] [Abstract][Full Text] [Related]
11. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384 [TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Hsu CY; Yung BY Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783 [TBL] [Abstract][Full Text] [Related]
14. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Liu WH; Yung BY Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708 [TBL] [Abstract][Full Text] [Related]